{"status": "ok", "totalResults": 3, "articles": [{"source": {"id": "usa-today", "name": "USA Today"}, "author": "Bailey Schulz, Jessica Guynn", "title": "DJT, Trump Media and Technology Group stock skyrockets on Nasdaq - USA TODAY", "description": "Trump Media, the parent company of Donald Trump\u2019s Truth Social platform, is now trading on the Nasdaq stock exchange.", "url": "https://www.usatoday.com/story/money/2024/03/26/truth-social-djt-stock-price/73098540007/", "urlToImage": "https://www.usatoday.com/gcdn/authoring/authoring-images/2024/03/26/USAT/73110563007-gty-2115210319.jpg?crop=5999,3375,x0,y312&width=3200&height=1801&format=pjpg&auto=webp", "publishedAt": "2024-03-26T20:21:12Z", "content": "Buoyed by legions of avid supporters, Donald Trump made a bubbly debut on the Nasdaq stock exchange Tuesday.\r\nShares of Trump Media &amp; Technology Group soared like helium from the opening bell and\u2026 [+6033 chars]"}, {"source": {"id": "fox-news", "name": "Fox News"}, "author": "Kim Komando", "title": "Is Apple\u2019s new Journal app a major privacy nightmare? - Fox News", "description": "Apple's new Journal app has raised privacy concerns among Apple's userbase. Tech expert Kim Komando examines social media rumors and explains what steps to take to protect yourself.", "url": "https://www.foxnews.com/tech/apples-new-journal-app-major-privacy-nightmare", "urlToImage": "https://static.foxnews.com/foxnews.com/content/uploads/2024/03/GettyImages-852081606-scaled.jpg", "publishedAt": "2024-03-26T18:25:00Z", "content": "Join Fox News for access to this content\r\nPlus special access to select articles and other premium content with your account - free of charge.\r\nPlease enter a valid email address.\r\nBy entering your e\u2026 [+4029 chars]"}, {"source": {"id": null, "name": "PSU Connect"}, "author": null, "title": "Bharat Biotech commenced clinical trial of MTBVAC vaccine in India - PSU Connect", "description": "Bharat Biotech International Ltd said it started clinical trials of the Tuberculosis vaccine MTBVAC on adults in India. This is the first vaccine against Tuberculosis derived from a human source by the Spanish bio-pharmaceutical company, Biofabri.\r\n\r\nThe tria\u2026", "url": "https://www.psuconnect.in/news/bharat-biotech-commenced-clinical-trial-of-mtbvac-vaccine-in-india-/41948/", "urlToImage": "https://www.psuconnect.in/sdsdsd/", "publishedAt": "2024-03-26T07:47:45Z", "content": "Bharat Biotech International Ltd said it started clinical trials of the Tuberculosis vaccine MTBVAC on adults in India. This is the first vaccine against Tuberculosis derived from a human source by t\u2026 [+1173 chars]"}]}